The Immunoassay Handbook : theory and applications of ligand binding, ELISA and related techniques
This handbook encompasses a wide range of methods and gives an insight into the latest developments and applications in clinical and veterinary practice and in pharmaceutical and life science research
Сохранить в:
| Другие авторы: | |
|---|---|
| Формат: | Livre numérique |
| Язык: | Anglais |
| Опубликовано: |
[Amsterdam] :
Elsevier B. V.
2013, cop. 2013.
|
| Редактирование: | 4th edition. |
| Предметы: | |
| Online-ссылка: | Accès Université Orléans et IFPM |
| Примечание: |
Notice modifiée d après la consultation du 2017-03-15 Titre provenant de la page de titre du document numérique Version électronique de l'édition de Oxford : Elsevier, 2013 La pagination de l'édition imprimée correspondante est de 1013 p. Cyberlibris (ScholarVox) corpus Santé Type of computer file: Présentation en 84 fichiers correspondant aux différents chapitres, parties liminaires et index. Formats HTML, PDF, EPUB et Mobipocket |
| Autres localisations: | Voir dans le Sudoc |
| Variante du titre: | Theory and applications of ligand binding, ELISA and related techniques |
| Edition sous un autre format: | • The immunoassay handbook, theory and applications of ligand binding, ELISA and related techniques, edited by David Wild, 4th ed., Amsterdam, Elsevier, 2013, 1 vol. (XIX-1013 p.), 978-0-08-097037-0 |
Оглавление:
- Part 1: Immunoassay Fundamentals
- Chapter 1.1 - How to Use This Book
- Chapter 1.2 - Immunoassay for Beginners
- Chapter 1.3 - Immunoassay Performance Measures
- Part 2: Immunoassay Configurations
- Chapter 2.1 - Principles of Competitive and Immunometric Assays (Including ELISA)1
- Chapter 2.2 - Non-competitive Immunoassays for Small Molecules the Anti-complex and Selective Antibody Systems
- Chapter 2.3 - Homogeneous Immunoassays
- Chapter 2.4 - Lateral Flow Immunoassay Systems: Evolution from the Current State of the Art to the Next Generation of Highly Sensitive, Quantitative Rapid Assays
- Chapter 2.5 - Ambient Analyte Assay
- Chapter 2.6 - Free Analyte Immunoassay
- Chapter 2.7 - Qualitative Immunoassay Features and Design
- Chapter 2.8 - Detection of Antibodies Relevant to Infectious Disease
- Chapter 2.9 - Microsphere-Based Multiplex Immunoassays: Development and Applications Using Luminex® xMAP® Technology
- Chapter 2.10 - Lab-on-a-Chip, Micro- and Nanoscale Immunoassay Systems, and Microarrays
- Chapter 2.11 - Immunological Biosensors
- Chapter 2.12 - Surface Plasmon Resonance in Binding Site, Kinetic, and Concentration Analyses
- Chapter 2.13 - Measurement of Single Protein Molecules Using Digital ELISA
- Part 3: Immunoassay Components
- Chapter 3.1 - Antibodies
- Chapter 3.2 - Signal Generation and Detection Systems (Excluding Homogeneous Assays)
- Chapter 3.3 - Separation Systems
- Chapter 3.4 - Conjugation Methods
- Chapter 3.5 - Standardization and Calibration
- Chapter 3.6 - Calibration Curve Fitting
- Part 4: Related Techniques
- Chapter 4.1 - The Foundations of Immunochemistry
- Chapter 4.2 - Immunohistochemistry and Immunocytochemistry
- Part 5: Immunoassay Development
- Chapter 5.1 - Practical Guide to ELISA Development
- Chapter 5.2 - Method Evaluation A Practical Guide
- Chapter 5.3 - Interferences in Immunoassay
- Chapter 5.4 - Immunoassay Development in the In Vitro Diagnostic Industry
- Part 6: Immunoassay Implementation
- Chapter 6.1 - Sample Collection, Including Participant Preparation and Sample Handling
- Chapter 6.2 - Quality Assurance
- Chapter 6.3 - Point-of-Care Testing
- Chapter 6.4 - Choosing an Automated Immunoassay System
- Chapter 6.5 - Immunoassay Troubleshooting Guide
- Part 7: Immunoassay Product Technology
- Chapter 7.1 - Introduction to Immunoassay Product Technology in Clinical Diagnostic Testing
- Chapter 7.2 - Market Trends
- Chapter 7.3 - Lateral Flow and Consumer Diagnostics
- Chapter 7.4 - Consumer Diagnostics Clearblue Pregnancy and Fertility Testing
- Chapter 7.5 - The Triage® System
- Chapter 7.6 - Stratus® CS Acute Care STAT Fluorometric Analyzer
- Chapter 7.7 - IMx®1
- Chapter 7.8 - AxSYM®
- Chapter 7.9 - Abbott ARCHITECT® Family of Analyzers
- Chapter 7.10 - ADVIA Centaur® XP
- Chapter 7.11 - IMMULITE® and IMMULITE 1000
- Chapter 7.12 - IMMULITE® 2000 and IMMULITE 2000 XPi
- Chapter 7.13 - VITROS® ECiQ Immunodiagnostic System, VITROS® 3600 Immunodiagnostic System, and VITROS® 5600 Integrated System
- Chapter 7.14 - VITROS® Immuno-Rate and MicroTip Assays
- Chapter 7.15 - Access 2
- Chapter 7.16 - DxI 600 and DxI 800
- Chapter 7.17 - Elecsys® Immunoassay Systems
- Chapter 7.18 - PRISM
- Chapter 7.19 - Phadia Laboratory Systems
- Part 8: Immunoassay Applications Other Than Clinical Chemistry
- Chapter 8.1 - Immunoassay Applications in Veterinary Diagnostics
- Chapter 8.2 - Ligand Binding Assays in Drug Development
- Part 9: Immunoassay Clinical Applications (Human)
- Chapter 9.1 - Clinical Concepts
- Chapter 9.2 - Thyroid
- Chapter 9.3 - The Adrenal Cortex
- Chapter 9.4 - Bone and Calcium Metabolism
- Chapter 9.5 - Infertility
- Chapter 9.6 - In Vitro Fertilization and Embryo Transfer (IVF-ET)
- Chapter 9.7 - Hirsutism and Virilization in the Female
- Chapter 9.8 - Pregnancy
- Chapter 9.9 - Growth and Growth Hormone Deficiency
- Chapter 9.10 - Diabetes Mellitus
- Chapter 9.11 - Hematology
- Chapter 9.12 - Cardiac Markers
- Chapter 9.13 - Cancer Markers
- Chapter 9.14 - Allergy
- Chapter 9.15 - Autoimmune Disease
- Chapter 9.16 - Gastrointestinal Tract
- Chapter 9.17 - Hepatitis
- Chapter 9.18 - HIV-1 and HIV-2: Causative Agents of AIDS
- Chapter 9.19 - Viral Diseases1
- Chapter 9.20 - Bacterial Diseases1
- Chapter 9.21 - Parasites and Fungi
- Chapter 9.22 - Therapeutic Drug Monitoring (TDM)
- Chapter 9.23 - Drugs of Abuse

